上正恒泰5个项目入选LegalOne 2024年度中国区杰出交易及案例榜单

release time 2025.08.19 author

2025年8月15日，全球性法律评级机构LegalOne公布了“2024年度中国区杰出交易及案例（Deals of the Year – China 2024）”榜单。上正恒泰凭借卓越实力，共有五个项目成功入选，覆盖资本市场、跨境并购、争议解决等多个领域。

入选的杰出交易/案例

<按照榜单发布顺序排列>

钢铁企业与大宗商品产业数据服务商数据权益纠纷案

Significant data processing right dispute in China between data services provider and steel enterprise

主办团队：李备战、杨如意、宋涵

案例链接：https://www.legaloneglobal.com/deal/d-1736478993397

睿励科学仪器近5亿元战略融资

Raintree Scientific Instruments secures CNY 500 million strategic financing

主办团队：郭蓓蓓、程硕

案例链接：https://www.legaloneglobal.com/deal/d-1736738503245

SZGK房地产业务及相关资产剥离

Sensteed High-Tech completes divestiture of its real estate business

主办团队：李备战、程硕

案例链接：https://www.legaloneglobal.com/deal/d-1736826123744

新光维医疗科技（苏州）股份有限公司与波士顿科学达成包括指定产品的全球经销、技术合作和开发等在内的合作伙伴关系

Scivita Medical forms strategic partnership with Boston Scientific

主办团队：刘阳芳、郑重

案例链接：https://www.legaloneglobal.com/deal/d-1736911592756

欧资企业个人信息出境标准合同备案

Successful filing for standard contract of personal information outbound transfer

主办团队：杨澜波

案例链接：https://www.legaloneglobal.com/deal/d-1736997362082

该榜单由LegalOne研究团队独立统计，根据项目本身的难度、复杂性、借鉴性、社会影响力、经济意义等维度作出分析评价，统计了LegalOne收录并作出评价的各律所于2024年完成的交易/案例数量，以及相应的LegalOne Merits各个评级的数量。LegalOne是一家独立运作的全球性商业交易及争议解决案例研究及评价机构，对全球法律、商业专业人士申报的交易或案例进行评估，杰出的项目会获得LegalOne Merits评级认可。

more content

Zhong Zheng

Associate

Shanghai

zhengzhong@hengtai-law.com
021-68816261
Corporate and M&A/Dispute Resolution/Healthcare and Life Sciences/Foreign-related Business/Labor and Employment
Chinese、English

Roy Yang

Partner/Director of executive committee

Shanghai

roy@hengtai-law.com
021-68816261
Corporate and M&A/Dispute Resolution/Intellectual Property
Chinese、English

Lanbo Yang

Managing Partner

Shanghai

lanboyang@hengtai-law.com
021-68816261
Corporate and M&A/Private Equity and Investment Funds/Dispute Resolution/Healthcare and Life Sciences/Compliance
Chinese、English

Angela Liu

Managing partner

Shanghai

angelaliu@hengtai-law.com
021-68816261
Corporate and M&A/Private Equity and Investment Funds/Securities and Capital Market/Healthcare and Life Sciences/Foreign-related Business
Chinese、English

Beizhan Li

Partner

Shanghai

libeizhan@hengtai-law.com
021-68816261
Corporate and M&A/Private Equity and Investment Funds/Dispute Resolution/Securities and Capital Market
Chinese

Beibei Guo

Partner

Shanghai

gracieguo@hengtai-law.com
021-68816261
Corporate and M&A/Private Equity and Investment Funds/Dispute Resolution/Securities and Capital Market
Chinese

xinwenzixunzhengwuredianrongmeitigongzhonghaocitu-679.jpg

Han Song

Associate

Shanghai

songhan@hengtai-law.com
021-68816261
Dispute Resolution/Intellectual Property
Chinese

zhengwuzixunxinwentongzhirongmeitigongzhonghaoshoutu.jpg

Shuo Cheng

Associate

Shanghai

chengshuo@hengtai-law.com
021-68816261
Corporate and M&A/Private Equity and Investment Funds/Dispute Resolution/Securities and Capital Market
Chinese、English